[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2016 Italy Nucleic Acid Testing/NAT Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, Competitive Strategies, Emerging Opportunities-Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing

November 2015 | 1117 pages | ID: 2BADD9FBAE4EN
Venture Planning Group

US$ 5,360.00 US$ 6,700.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report presents a comprehensive analysis of the Italian molecular diagnostics market, including:
  • Major issues pertaining to the Italian molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
  • An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.
  • Ten-year test volume and reagent sales forecasts for the following categories:
  • Infectious Diseases
  • Genetic Diseases
  • Cancer
  • Paternity Testing/HLA Typing
  • Forensic Testing
    • Review of testing methodologies an instrumentation technologies.
    • Feature comparison of automated and semiautomated analyzers.
    • Sales and market shares of leading suppliers.
    • Over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products.
    • Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
    • Alternative market penetration strategies.
    • Potential market entry barriers and risks.
    • Business planning issues and concerns.
    Contains 1,117 pages and 55 tables
  • 1. INTRODUCTION

    2. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

    A. Instrumentation
    B. Reagent Kits and Test Systems/panels
    C. Computers, Software and Automation
    D. Auxiliary Products
      3. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
      4. ALTERNATIVE MARKET PENETRATION STRATEGIES
    A. Internal Development
    B. Collaborative Arrangements
    C. University Contracts
    D. Distribution Strategies For Decentralized Testing Markets

    5. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

    A. Market Maturity
    B. Cost Containment
    C. Competition
    D. Technological Edge And Limitations
    E. Patent Protection
    F. Regulatory Constraints
    G. Decentralized Testing Market Challenges

    6. WORLDWIDE MARKET AND TECHNOLOGY REVIEW

    A. DNA Sequencing
      1. INTRODUCTION
      2. SEQUENCING METHODS
      3. AUTORADIOGRAPHY
      4. THE HUMAN GENOME PROJECT
      5. SEQUENCING AUTOMATION
      6. IMAGE SCANNERS
      7. FLUORESCENT DETECTION
      8. GENE PROFILING
      9. GENE EXPRESSION
      10. POLYMORPHISM SCREENING
      11. PROTEIN INTERACTION NETWORKS
    B. DNA and RNA Probe Technologies
      1. BASIC PRINCIPLES
      2. PROBE PREPARATION
      3. THE DNA PROBE TEST
      4. TEST FORMATS
      5. LABELING TECHNIQUES
      6. AMPLIFICATION METHODS
    C. Detection Technologies
      1. RADIOACTIVE METHODS
        a. Overview
        b. Major Isotopes
          P-32
          S-35
          H-3
          I-125
      2. NON-ISOTOPIC METHODS
        a. Enzymatic Labels
        b. Chemical Labeling
          Indirect Chemical Labeling
          Direct Chemical Labeling
        c. Fluorescence
        d. Chemiluminescence
        e. Electrical Conductivity
    D. Molecular Diagnostic Instrumentation Review
      1. ABBOTT LCX
      2. BECKMAN COULTER/BIOMEK FK
      3. BD VIPER SYSTEM WITH XTR TECHNOLOGY
      4. BD INNOVA
      5. BECTON DICKINSON SDA
      6. BIOMERIEUX NUCLISENS EASYMAG
      7. BIOMERIEUX NUCLISENS EASYQ AND MINIMAG
      8. BIO-RAD GENESCOPE
      9. CEPHEID GENEXPERT
      10. CURETIS UNYVERO
      11. GENMARK DX ESENSOR XT-8
      12. HOLOGIC/GEN-PROBE PANTHER
      13. HOLOGIC/GEN-PROBE TIGRIS/DTS
      14. HTG MOLECULAR EDGE
      15. LIFE TECHNOLOGIES QUANTSTUDI      DX
      16. QIAGEN QIASYMPHONY RGQ
      17. ROCHE COBAS AMPLICOR
      18. ROCHE COBAS TAQMAN
      19. ROCHE COBAS TAQMAN
      20. ROCHE COBAS TAQMAN AMPLIPREP
      21. ROCHE LIGHCYCLER
      22. ROCHE COBAS 4800
      23. ROCHE COBAS S
      24. SIEMENS VERSANT
      25. TECAN LS SERIES
    E. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip
      Liquid Transportation and Mixing
      Separation
      Reaction
      Detection
    F. Pharmacogenomics
    G. Major Applications
      1. MICROBIOLOGY/INFECTIOUS DISEASES
        a. Overview
        b. Major Infectious Diseases
          AIDS: HIV/HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II
          Adenovirus
          Aeromonas
          Anthrax/Bacillus Anthracis
          Arboviruses
          Babesiosis
          Bacillary Epithelioid Angiomatosis (BEA) and Other Bartonella (Rochalimaea)
          Blastocystis Hominis
          Brucella
          Campylobacter
          Candida
          Chagas Disease
          Chancroid
          Chlamydia
          Clostridium Difficile
          Coronaviruses
          Coxsackieviruses
          Creutzfeldt-Jakob’s Disease
          Cryptosporidium Parvum
          Cyclospora Cayetanensis
          Cytomegalovirus
          Ebola Virus
          E. Coli
          EchoVirus
          Encephalitis
          Enteroviruses
          Epstein-Barr Virus
          Giardia Lamblia
          Gonorrhea
          Granuloma Inguinale
          Hantavirus
          Helicobacter Pylori
          Hepatitis: HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, ALT/SGPT
          Herpes Simplex Virus
          Human Herpes Virus-6 (HHV-6)
          Influenza Viruses
          Legionella
          Lyme Disease
          Lymphogranuloma Venereum (LGV)
          Malaria
          Measles (Rubeola)
          Meningitis
          Microsporidium
          Mononucleosis
          Mumps
          Mycoplasma
          Papillomaviruses
          Parvovirus B19
          Pneumonia
          Polyomaviruses
          Pseudomonas Aeruginosa
          Rabies
          Respiratory Syncytial Virus (RSV)
          Rhinoviruses
          Rotavirus
          Rubella
          Salmonellosis
          Septicemia
          Shigellosis
          Staphylococcus Aureus
          Streptococci
          Syphilis
          Toxoplasmosis
          Trichomonas Vaginalis
          Tuberculosis
          Vibrio
          West Nile Virus
          Yersina
      2. CANCER TESTING
        a. Overview
        b. Major Cancer Types
    * Prostate
    * Lung
    * Colon and Rectum
    * Breast
    * Skin
    * Uterine
    * Leukemia
    * Oral
        c. Oncogenes
          Abl/abl-bcr
          AIB1
          BCL-2
          BRCA1
          CD44
          C-fos
          C-myb
          C-myc
          CYP17
          Erb-B
          HPC1
          N-myc
          P40
          P51
          P53
          PIK3CA
          PTI-1
          Ras
          Reg
          Sis
          Src
      3. GENETIC DISEASES
        a. Overview
        b. Nucleic Acid Amplification
        c. Chromosome Imaging
        d. Genomics Technologies
        e. Proteomics Technologies
        f. Current Pharmacogenomic Tests
        g. Future Pharmacogenomic Testing
        h. Major Diseases
    * Achondroplasia
    * Autosomal Dominant Polycystic Kidney
    Disease
    * Cancer
    * Cosmetogenomics
    * Cystic Fibrosis
    * Down's Syndrome
    * Duchenne and Becker Muscular Dystrophy
    * Factor V (Leiden)
    * Factor IX Deficiency
    * Fragile X Syndrome
    * Heart Disease
    * Hemochomatosis
    * Hemophilia
    * Huntington's Disease
    * Maternal-Fetal Incompatibility
    * Multiple Endocrine Neoplasia
    * Phenylketonuria (PKU)
    * Polycystic Kidney Disease (PKD)
    * Prenatal Screening
    * Retinitis Pigmentosa
    * Retinoblastoma
    * Sickle Cell Anemia
    * Spinal Muscular Atrophy
    * Vitamin B12 Metabolism
        i. Social Issues and Concerns
      4. FORENSIC TESTING
        a. Overview
        b. Multilocus and Single Locus Probes
    * Multilocus Probes
    * Single Locus Probes
    * PCR and RFLP
        c. The FBI
        d. DNA Profile Data Banks
      * U.S.A.
      * U.K.
        e. Judicial Implementation
        f. Major Crime Categories
        g. Factors Contributing to the DNA Probe
    Market Expansion
    * Technology Availability
    * Use of Hair as Evidence
        h. Wildlife Forensics
      5. PATERNITY TESTING/HLA TYPING
      6. OTHER APPLICATIONS
        a. Disease Susceptibility Testing
        b. Cardiovascular Diseases
        c. Diabetes
        d. Alzheimer's Disease
        e. Periodontal Disease
        f. Plasma Purification
        g. Organ Transplantation
        h. Water Contamination
        i. Other
    H. Competing/complementing
      1. MONOCLONAL ANTIBODIES/IMMUNOASSAYS
      2. RNA PROBES
      3. TWO-DIMENSIONAL ELECTROPHORESIS
      4. FLOW CYTOMETRY

    7. ITALY MOLECULAR DIAGNOSTICS MARKET

    A. Executive Summary
    B. Business Environment
    C. Market Structure
    D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares
      8. COMPETITIVE ASSESSMENTS
    Abbott
    Affymetrix
    Agilent Technologies
    Applied Gene Technologies
    Arca Biopharma
    Beckman Coulter/Danaher
    Becton Dickinson
    Biokit
    bioMerieux
    Bio-Rad
    Biotest
    Cepheid
    CellMark Forensics/LabCorp
    Decode Genetics
    Diadexus
    Eiken
    Elitech Group
    Enzo
    Exact Sciences
    Fujirebio
    Grifols
    Hologic/Gen-Probe
    Illumina
    Kreatech/Leica
    Li-Cor Biosciences
    Monogram Biosciences/LabCorp
    Myriad Genetics
    Ortho-Clinical Diagnostics
    Perkin Elmer/Caliper
    Proteome Sciences
    Qiagen
    Roche
    Scienion
    Sequenom
    Shimadzu
    Siemens
    Sierra Molecular
    Takara Bio
    Tecan Group
    Thermo Fisher

    13. APPENDIX: MAJOR UNIVERSITIES AND RESEARCH CENTERS DEVELOPING MOLECULAR DIAGNOSTIC TECHNOLOGIES

    LIST OF TABLES

    Major Companies Developing or Marketing AIDS Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Adenovirus Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Bartonella Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Campylobacter Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Candida Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Chlamydia Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Clostridium Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Coronavirus Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Cryptosporidium Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing CMV Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Echovirus Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Enterovirus Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing EBV Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Giardia Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Gonorrhea Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Hantavirus Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Helicobacter Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Hepatitis Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Herpes Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Influenza Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Legionella Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Lyme Disease Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Measles Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Meningitis Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Mononucleosis Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Mumps Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Mycoplasma Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Pneumonia Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing RSV Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Rotavirus Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Rubella Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Salmonella Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Septicemia Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Shigella Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Streptococci Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Syphilis Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Toxoplasmosis Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Trichomonas Molecular Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Tuberculosis Molecular Diagnostic and Other Direct Identification Tests
    Oncogenes Potential Application in Cancer Diagnosis
    Major Companies Developing or Marketing Cancer Molecular Diagnostic Tests
    Major Companies Developing or Marketing Molecular Diagnostic Tests For Genetic Diseases
    Italy Molecular Diagnostics Test Volume And Sales By Major Application
    Italy Laboratories Performing DNA Sequencing By Market Segment
    Italy Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
    Italy Molecular Diagnostics Test Volume By Major Application
    Italy Major Infectious Disease Test Volume by Assay
    Italy Major Infectious Disease Test Volume by Method
    Italy Molecular Diagnostics Market By Major Application
    Italy Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers
    Italy Major Infectious Disease Diagnostics Market by Assay
    Italy AIDS Testing Market Estimated Sales by Major Supplier
    Italy CMV Testing Market Estimated Sales by Major Supplier
    Italy Gonorrhea Testing Market Estimated Sales by Major Supplier
    Italy Hepatitis Testing Market Estimated Sales by Major Supplier
    Italy Hepatitis C Testing Market Estimated Sales by Major Supplier
    Italy HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
    Italy Herpes Testing Market Estimated Sales by Major Supplier
    Italy Influenza Testing Market Estimated Sales by Major Supplier
    Italy Meningitis Testing Market Estimated Sales by Major Supplier
    Italy Mycoplasma Testing Market Estimated Sales by Major Supplier
    Italy RSV Testing Market Estimated Sales by Major Supplier


    More Publications